Our News on Newswise

Newswise: Chad.Rusthoven.Headshot.jpg

FIRE-SCLC analysis: Largest ever study of first-line radiosurgery for brain metastases from small cell lung cancer

The international First-line Radiosurgery for Small-Cell Lung Cancer (FIRE-SCLC) analysis led by University of Colorado Cancer Center researchers and published today in JAMA Oncology shows no overall survival benefit from whole-brain radiation...
4-Jun-2020 6:10 PM EDT Add to Favorites

Newswise: Daniel.Sherbenou.jpg

Colorado tool, My-DST, may pick best multiple myeloma treatment

University of Colorado Cancer Center team uses liquid biopsy to predict multiple myeloma drug resistance and sensitivity.
28-May-2020 12:10 PM EDT Add to Favorites

Newswise: Emily.Simons.jpg

Variations in side effect reporting makes drug safety unclear

University of Colorado Cancer Center study of early-phase clinical trials finds variations in reporting of drug side effects, potentially obscuring safety.
28-Apr-2020 2:30 PM EDT Add to Favorites

Newswise: Tejas.Patil.jpg

Series of Rare Right-Colon Twists Highlights Need for Doctor Vigilance with New, Targeted Anti-Cancer Drugs

Study: with smaller clinical trials, it may be up to doctors to notice rare drug side effects
22-Apr-2020 10:05 AM EDT Add to Favorites

Newswise: Sabrina.Spencer.jpg

Colorado study overturns ‘snapshot’ model of cell cycle in use since 1974

Live, single-cell imaging shows that cells continuously integrate the influence of growth factors, not just during G1 phase of cell cycle, as previously thought.
2-Apr-2020 3:05 PM EDT Add to Favorites

Newswise: Benjamin.Bitler.jpg

Experimental medication to prevent heart disease may treat chemo-resistant ovarian cancer

University of Colorado Cancer Center group shows CPT1A may be necessary for ovarian cancer spread, chemo-resistance. Moves toward clinical trial of CPT1A inhibitor, etomoxir, against chemo-resistant ovarian cancer.
26-Mar-2020 11:55 AM EDT Add to Favorites

Newswise: Adam.Green.jpg

Study: Despite failures, chemo still promising against dangerous childhood brain cancer, DIPG

Chemotherapy has been so unsuccessful against DIPG that researchers have questioned whether chemotherapy drugs are even able to reach the cancer. University of Colorado Cancer Center study shows, "... medicine does reach DIPG tissue in good...
25-Mar-2020 4:50 PM EDT Add to Favorites

Newswise: Andrew.Thorburn.jpg

Leading chloroquine scientists weigh in on drug as possible COVID-19 treatment

“Two independent sources with the same scientific finding make you think it’s true,” says Jean Mulcahy-Levy, MD, investigator at CU Cancer Center and associate professor in the CU School of Medicine Department of Pediatrics.
19-Mar-2020 4:35 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: Brewer.2.jpg

New mental health challenges for cancer patients during COVID-19

Benjamin Brewer, PsyD, is a University of Colorado Cancer Center investigator and health psychologist at the UCHealth University of Colorado Hospital Bone Marrow Transplant Program. Here CU Cancer Center talks with Dr. Brewer about his patients’...
6-Apr-2020 12:05 PM EDT

Newswise: Neil.Box.jpg.JPG

Will One Bad Sunburn Give You Skin Cancer?

27-Jul-2015 11:05 AM EDT

Newswise: Aisner_Dara_2010.jpg

Oncologists: How to Talk With Your Pathologist About Cancer Molecular Testing

An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges of collaboration between oncologists and pathologists in the context of molecular testing patient tumor samples.
30-May-2014 4:00 PM EDT

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

The mission of the University of Colorado Cancer Center is to discover, develop and deliver breakthroughs in diagnosis, treatment, and prevention that improve cancer care locally, nationally and globally. These efforts form the basis of a comprehensive spectrum of translational prevention, diagnosis, treatment, survivorship and outreach programs and provide a framework for training the next generation of cancer researchers and physicians.

Contacts

Garth Sundem
Science Writer
Cancer Science

garth.sundem@ucdenver.edu

303-724-6441

Twitter

close
0.7832